Small platform supporting state-of-the-art technology for fast PCR protocols introduced at American Society of Human Genetics meeting in Montreal The new LightCycler Nano instrument shares the ...
PENZBERG, Germany--(BUSINESS WIRE)-- Roche (SIX: RO, ROG; OTCQX: RHHBY) and Exiqon (NASDAQ OMX: EXQ) join marketing forces for Roche Applied Science´s RealTime ready assays and Exiqon`s miRCURY LNA™ ...
Roche has an ongoing program to develop a real-time PCR assay that detects mutations in the PI3K oncogene. The assay will run on Roche's cobas ® 4800 System. Roche intends to make the PI3K PCR assay ...
Large-scale, PCR-based gene analysis can only be performed if signals are generated, captured and analyzed in a highly reproducible manner. More precisely, thermal control, optical readout and the ...
Technology to be used in Roche’s new line of RealTime ready qPCR assays. Roche Diagnostics and Exiqon amended a 2005 license and distribution agreement for the Universal ProbeLibrary (UPL), which is ...
Real-time PCR plays a foundational role in gene expression studies, disease analysis, and molecular diagnostics. However, success depends on precise reaction setup, optimized assays, and accurate ...
The new LightCycler Nano instrument shares the state-of-the-art technology of the LightCycler portfolio, producing high quality data in qPCR, genotyping, and high resolution melting on a small ...
As indicated by respective links on their websites, each system will complement the cooperator ´s product portfolio. A bundle of measures like webinars and seminars and linked internet appearances are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results